Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenSage Prebiotics is a Canadian biotechnology company developing coconut-derived prebiotic products for aquaculture, animal health, and human health. Its lead product, Pretego, is a natural mannan-oligosaccharide ingredient intended to support digestive and immune health while reducing reliance on antibiotics. The company’s initial commercial focus appears to be aquaculture, particularly shrimp and salmon, where infections and poor feed conversion drive major economic losses. GreenSage is also exploring broader applications in companion animals and human health, including gastrointestinal and urinary-health related use cases. The business is positioned as a sustainable, science-based platform built around valorizing coconut processing residuals into health-promoting bioactive ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Sage.